TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21076160

Group type: EXPERIMENTAL
Intervention: Presence of pleomorphism (PL) in M-VT episodes
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Presence of multiple morphologies (MM) in M-VT episodes
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mortality in patients with pleomorphism (PL)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mortality in patients with multiple morphologies (MM)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mortality in female patients
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Predictors of mortality
Number of subjects: 315
Study: 18483853

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin (PCb) every 3 weeks
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Docetaxel and gemcitabine (GDoc) every 3 weeks
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel (Pw)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Docetaxel and gemcitabine (GDoc)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Paclitaxel and carboplatin (PCb)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Quality of life (QoL) assessment
Number of subjects: 416

Group type: COMPARATOR
Intervention: Cost analysis
Number of subjects: 416
Study: 17455445

Group type: EXPERIMENTAL
Intervention: SM2: application of a methyl methacrylate‐based bonding agent (Vitacol)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SM3: air abrasion with 30‐microm silicone oxide plus silane
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SM4: SM3 plus SM2
Number of subjects: 24

Group type: COMPARATOR
Intervention: SM1: No surface treatment (control)
Number of subjects: 24
Study: 14683738

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 8986

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8986
Study: 11772792

Group type: EXPERIMENTAL
Intervention: Slow rewarm (n = 65)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Conventional warming (Control; n = 100)
Number of subjects: 165
Study: 9468065

Group type: EXPERIMENTAL
Intervention: Altitude exposure at 1,000 m and 2,500 m
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Altitude exposure
Number of subjects: 23
Study: 7893035

Group type: EXPERIMENTAL
Intervention: Isoflurane/alfentanil
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Propofol/alfentanil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Preincision hemodynamic variables
Number of subjects: 50
Study: 2575480

Group type: EXPERIMENTAL
Intervention: Bopindolol
Number of subjects: 86

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 86
Study: 82355

Group type: EXPERIMENTAL
Intervention: Zinc treatment
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Zinc + vitamin A treatment
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Vitamin A treatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 75
Study: 31490370

Group type: EXPERIMENTAL
Intervention: 12-week moderate-intensity exercise training
Number of subjects: 20
Study: 28535400

Group type: EXPERIMENTAL
Intervention: Cervista HPV HR test
Number of subjects: 3280

Group type: COMPARATOR
Intervention: Luminex XMAP technology
Number of subjects: 3280
Study: 26065499

Group type: EXPERIMENTAL
Intervention: Besifloxacin ophthalmic suspension 0.6%
Number of subjects: 123

Group type: COMPARATOR
Intervention: Moxifloxacin ophthalmic solution 0.5%
Number of subjects: 123
Study: 23084706

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 58
Study: 21243736

Group type: EXPERIMENTAL
Intervention: VeraTran (verapamil/trandolapril 180 mg/2 mg daily)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Trandolapril (2 mg daily)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Patients regressing to normoalbuminuria
Number of subjects: 281

Group type: COMPARATOR
Intervention: Patients not regressing to normoalbuminuria
Number of subjects: 281
Study: 19653080

Group type: EXPERIMENTAL
Intervention: Laplacian approximation (LAPLACE)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: GQ 9 points
Number of subjects: 551

Group type: COMPARATOR
Intervention: Methods implemented in SAS
Number of subjects: 551
Study: 16932987

Group type: EXPERIMENTAL
Intervention: Partnered teen mothers (African-Americans)
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Partnered teen mothers (Latinas)
Number of subjects: 751
Study: 15078378

Group type: EXPERIMENTAL
Intervention: Caudal tramadol (2 mg.kg(‐1) after surgery)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Caudal tramadol (2 mg.kg(‐1) before incision)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Intravenous tramadol (2 mg.kg(‐1) after surgery)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Intravenous tramadol (2 mg.kg(‐1) after anaesthesia induction)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Caudal tramadol (both preoperative and postoperative)
Number of subjects: 134
Study: 10764900

Group type: EXPERIMENTAL
Intervention: Phantom limb pain (PLP) patients
Number of subjects: 11

Group type: COMPARATOR
Intervention: Painfree amputees
Number of subjects: 11
Study: 9267140

Group type: EXPERIMENTAL
Intervention: Daily oral etoposide (25 mg) with concurrent radiation therapy (ERT group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Radiation therapy alone (RT group)
Number of subjects: 41
Study: 8454794

Group type: EXPERIMENTAL
Intervention: Maternal and infant food avoidance
Number of subjects: 288
Study: 3530128

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 203

Group type: COMPARATOR
Intervention: Moxalactam
Number of subjects: 203
Study: 29433537

Group type: EXPERIMENTAL
Intervention: Mobile-phone-based intervention (24 voice messages sent every 2 weeks)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Existing standard of care (control group)
Number of subjects: 640
Study: 26266659

Group type: EXPERIMENTAL
Intervention: Gln plus ED (total oral intake of 8862 mg Gln/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gln (oral intake of 8910 mg Gln/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gln plus ED
Number of subjects: 30
Study: 25622524

Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (semi-standardised including joint and soft tissue mobilisation, stretching, muscle retraining, functional retraining, and education)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Health education (control intervention with the same frequency and duration as the physiotherapy intervention)
Number of subjects: 20
Study: 23044768

Group type: EXPERIMENTAL
Intervention: Andrographis paniculata extract (HMPL-004) 1,200 mg daily
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Andrographis paniculata extract (HMPL-004) 1,800 mg daily
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 21039208

Group type: EXPERIMENTAL
Intervention: Acupuncture-like transcutaneous electrical nerve stimulation (AL-TENS)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no AL-TENS)
Number of subjects: 43
Study: 18389732

Group type: EXPERIMENTAL
Intervention: Single Bond Plus
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Adper Prompt
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 16548929

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Control (placebo or psychosocial interventions)
Number of subjects: 1071
Study: 12648032

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10725619

Group type: EXPERIMENTAL
Intervention: Amifostine (150 mg/m²) administered 15-30 min prior to each radiation session
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no amifostine)
Number of subjects: 26
Study: 9330416

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional Intermittent Mandatory Ventilation (IMV)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV) with late triggering (200-300 msec)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Augmented breaths
Number of subjects: 15
Study: 1526081

Group type: EXPERIMENTAL
Intervention: Enoxacin alone (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin after ranitidine (50 mg IV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin after pentagastrin (2 micrograms/kg SC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enoxacin after combined ranitidine and pentagastrin treatment
Number of subjects: 12
Study: 3516951

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (4500 rad to the breast/chest wall, and internal mammary, axillary and supraclavicular lymph nodes)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Surgical controls (modified radical mastectomy alone)
Number of subjects: 960
Study: 30901130

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg ketamine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 28233149

Group type: EXPERIMENTAL
Intervention: Post-monsoon CO2 concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Summer CO2 concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Winter CO2 concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CH4 concentrations in all seasons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-monsoon N2O concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Summer N2O concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Winter N2O concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Average concentrations of gases in commercial areas
Number of subjects: 0
Study: 26488927

Group type: EXPERIMENTAL
Intervention: Midline catheters
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard-length PVCs
Number of subjects: 211
Study: 24090395

Group type: EXPERIMENTAL
Intervention: 6-month scale and polish
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: 12-month scale and polish
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: 24-month scale and polish
Number of subjects: 369
Study: 21672319

Group type: EXPERIMENTAL
Intervention: Gasless laparoscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 100
Study: 19576339

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 201
Study: 17356531

Group type: EXPERIMENTAL
Intervention: Educational/behavioral intervention (small group seminars)
Number of subjects: 115

Group type: COMPARATOR
Intervention: No specific intervention (control group)
Number of subjects: 115
Study: 15297045

Group type: EXPERIMENTAL
Intervention: inactivated-gp120-depleted HIV-1 Immunogen plus antiretrovirals (ARTs)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: inactivated-gp120-depleted HIV-1 Immunogen
Number of subjects: 243

Group type: COMPARATOR
Intervention: antiretroviral therapy alone
Number of subjects: 243
Study: 12107551

Group type: EXPERIMENTAL
Intervention: IST-622 (280 or 525 mg/m² once daily for five consecutive days)
Number of subjects: 18
Study: 9730857

Group type: EXPERIMENTAL
Intervention: Vitamin E administration (500 i.u. twice daily for 4 weeks)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Vitamin E administration
Number of subjects: 7
Study: 8014585

Group type: EXPERIMENTAL
Intervention: lovastatin (40 mg b.i.d) + low cholesterol diet (mean 246 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: lovastatin (40 mg b.i.d) + high cholesterol diet (mean 1071 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: low cholesterol diet alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: high cholesterol diet alone
Number of subjects: 12
Study: 2900132

Group type: EXPERIMENTAL
Intervention: Urapidil (25 mg, increased to 50 mg if necessary)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31673086

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA) using Inbody 230 multifrequency analyzer
Number of subjects: 170
Study: 31019123

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg/day
Number of subjects: 45
Study: 28545498

Group type: EXPERIMENTAL
Intervention: SCOOT program (6 weeks of one-to-one scooter training by an experienced occupational therapist, training once or twice per week)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SCOOT program
Number of subjects: 40
Study: 26322280

Group type: EXPERIMENTAL
Intervention: Bupivacaine 1 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of bupivacaine-tramadol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 120
Study: 23434387

Group type: EXPERIMENTAL
Intervention: Live attenuated monovalent H1N1pdm09 vaccine
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: Live attenuated trivalent 2009-10 seasonal influenza vaccine
Number of subjects: 703

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 703
Study: 22097202

Group type: EXPERIMENTAL
Intervention: Biantong Huangqi Ointment (BHO), one dose daily during remission phase for 1 month
Number of subjects: 84

Group type: COMPARATOR
Intervention: Western medicine (WM) alone during onset phase
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Biantong Huangqi Ointment (BHO)
Number of subjects: 84
Study: 19797985

Group type: EXPERIMENTAL
Intervention: Aripiprazole 5 mg/day
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Aripiprazole 15 mg/day
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Aripiprazole (all doses)
Number of subjects: 218
Study: 17132483

Group type: EXPERIMENTAL
Intervention: Horizontal closure
Number of subjects: 43

Group type: COMPARATOR
Intervention: Vertical closure
Number of subjects: 43
Study: 15229392

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg/day)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 840
Study: 11771605

Group type: EXPERIMENTAL
Intervention: Laryngoscopic‐guided LMA insertion
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard insertion technique
Number of subjects: 149
Study: 9249998

Group type: EXPERIMENTAL
Intervention: HBOC‐201
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 18
Study: 8518768

Group type: EXPERIMENTAL
Intervention: Weighted vest exercise intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (discussion controls)
Number of subjects: 36
Study: 3224601

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Liquid formula meal
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Breakfast meal
Number of subjects: 30
Study: 29395476

Group type: EXPERIMENTAL
Intervention: Emotional responsiveness (RIAS composite of codes)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Question asking (RIAS coded communication)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Biomedical counseling (RIAS coded communication)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: RIAS-coded communication variables
Number of subjects: 84
Study: 28490512

Group type: EXPERIMENTAL
Intervention: Weight z score at 3 months preconception (zwt-3 mo)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Weight z score at 3 months postconception (zwt+7 mo)
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Weight z score at conception
Number of subjects: 670
Study: 25623617

Group type: EXPERIMENTAL
Intervention: NEXA (neuromuscular exercise)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: QS (quadriceps strengthening)
Number of subjects: 100
Study: 22930239

Group type: EXPERIMENTAL
Intervention: Laparotomy for gynecologic cancer
Number of subjects: 181
Study: 20924393

Group type: EXPERIMENTAL
Intervention: Granular PGX (2.5, 5, and 7.5 g) at breakfast
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Granular PGX (5 g) consumed from -45 to +15 min before and after a meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Capsules containing 3, 4.5, and 6 g PGX consumed with the evening meal
Number of subjects: 10
Study: 18191645

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (AT) 800 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gamma-tocopherol (GT) 800 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of AT and GT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16679981

Group type: EXPERIMENTAL
Intervention: Whole Milk (WM)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Fat-Free Milk (FM)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Isocaloric Milk (IM)
Number of subjects: 3
Study: 15283007

Group type: COMPARATOR
Intervention: Placebo plus CBT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100 mg modafinil plus CBT
Number of subjects: 30

Group type: COMPARATOR
Intervention: 100 mg modafinil plus contact control (monitor‐only condition)
Number of subjects: 30
Study: 11389575

Group type: EXPERIMENTAL
Intervention: Salbutamol (SB), max. 2.5 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB), max. 0.5 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combination of Salbutamol and Ipratropium bromide
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 17
Study: 9431826

Group type: EXPERIMENTAL
Intervention: Buffered ketoprofen (12.5 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Buffered ketoprofen (25 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unbuffered ketoprofen (12.5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unbuffered ketoprofen (25 mg)
Number of subjects: 24
Study: 8390644

Group type: EXPERIMENTAL
Intervention: Community-based intervention with public health nursing and homemaker services for up to 8 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (discharged at physician's discretion)
Number of subjects: 100
Study: 3566996

Group type: EXPERIMENTAL
Intervention: Naloxone 2 mg, i.v. during surgery
Number of subjects: 2

Group type: COMPARATOR
Intervention: Isoflurane in oxygen (1.5% end‐tidal)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Isoflurane in 67% nitrous oxide in oxygen (0.75% end‐tidal)
Number of subjects: 2
Study: 31532137

Group type: EXPERIMENTAL
Intervention: Thread-embedding therapy in addition to routine rehabilitation treatment (physical therapy, spleen-strengthening, kidney-nourishing, Governor Vessel-regulating massage, vibroacoustic therapy, and scalp acupuncture), applied at acupoints (LI15, SJ14, SI11, ST25, C4, L1, L4), 6-8 acupoints selected each time, once a week for 4 weeks, with 3 courses total.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine rehabilitation treatment (physical therapy, spleen-strengthening, kidney-nourishing, Governor Vessel-regulating massage, vibroacoustic therapy, and scalp acupuncture).
Number of subjects: 70
Study: 27100318

Group type: EXPERIMENTAL
Intervention: Smith machine bench press
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Barbell bench press
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Dumbbell bench press
Number of subjects: 27
Study: 26467531

Group type: EXPERIMENTAL
Intervention: Xenon
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 30
Study: 23641817

Group type: EXPERIMENTAL
Intervention: Lung Support Formula (1 capsule twice a day for 12 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (1 capsule twice a day for 12 weeks)
Number of subjects: 100
Study: 21341922

Group type: EXPERIMENTAL
Intervention: Brief behaviorally based smoking-cessation treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed treatment control condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Craving
Number of subjects: 0
Study: 19054718

Group type: EXPERIMENTAL
Intervention: Individualized telephone patient education intervention delivered 1-2 days pre-discharge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individualized telephone patient education intervention delivered 1-2 days post-discharge
Number of subjects: 0
Study: 17351510

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/d
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study: 14965835

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 11702100

Group type: EXPERIMENTAL
Intervention: Alteplase 100 mg (5 patients)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Heparin 1,750 IU/h (2 patients)
Number of subjects: 7
Study: 9131360

Group type: EXPERIMENTAL
Intervention: Professionally led support group intervention combining group therapy techniques with psychoeducational strategies in six weekly sessions
Number of subjects: 46
Study: 7964860

Group type: EXPERIMENTAL
Intervention: Intravenous high-dose immunoglobulins
Number of subjects: 12

Group type: COMPARATOR
Intervention: GTOE supplementation therapy
Number of subjects: 12
Study: 2825505

Group type: EXPERIMENTAL
Intervention: Low-glycemic-index diet
Number of subjects: 6

Group type: COMPARATOR
Intervention: High-glycemic-index diet
Number of subjects: 6
Study: 31301533

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (BPG) administered every 4 weeks
Number of subjects: 916

Group type: COMPARATOR
Intervention: No medical intervention (Control)
Number of subjects: 916